Healthcare Researches

https://www.coherentmarketinsights.com/insight/request-sample/730

Patient Flow Management Solutions Market - Growth, Trends, and Forecasts (2017–2025)

4:46 pm 3 October 2017

Patient Flow Management Solutions Market Overview:

Patient flow management solutions are used to track the records, information of the patient or the flow of equipment between organizations, and also to manage the patient reception, routing, and queuing. The solutions use real-time data inputs in combination with analytical and statistical software to design effective workflow. The healthcare centers or organizations are upgrading the patient flow management solutions to improve cost management and better utilization of their resources. Patient flow management solutions focus on increasing interaction between staff and patients, patient-centered care, reduction in waiting time, enhancing patient care quality, satisfaction, and also decreasing the paperwork.

Recently in June 2017, Aptean, a leading global provider of Mission Critical Enterprise Software Solutions, announced the acquisition of FDM Software, which will combine and help create a single source for best of breed public safety solutions for local municipalities and provide them a better customer experience. Hence, this will also help in building opportunities for healthcare sector to build an integrated platform with hospital patient flow capabilities. Furthermore, Aptean attended SNACKEX 2017, a global sourcing event for the savory snacks industry, which took place in Vienna, Austria on June 21^st and 22nd, 2017.

Fill the form for an exclusive sample of Patient Flow Management Solutions Market @

The company, GRM Information Management Services, Inc., recently (2017) implemented a new digital pathology lab automation solution for the top healthcare system in the U.S., which is intended to offer clients a more comprehensive view of pathology operations, thereby improving efficiency and delivering significant savings.

Patient Flow Management Solutions Market Taxonomy

Patient Flow Management Solutions Market, by Product Type:

Integrated

Standalone

Patient Flow Management Solutions Market, by Type:

Real-time locating system

Event driven solutions

Patient Flow Management Solutions Market, by Component:

Hardware

Software

Services

Patient Flow Management Solutions Market, by Delivery Mode:

Web-based

Cloud- based

On- premise

Patient Flow Management Solutions Market, by End User:

Hospitals

Clinics

Others

Patient Flow Management Solutions Market, by Geography:

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Technological advancements and highly beneficial applications are expected to boost the market growth

Factors driving the market growth include growing demand for cloud-based models, increase in penetration and usage of smartphones, rise in product launches, and collaboration & partnerships among market players. Moreover, high return on investment achieved by the adoption of these solutions, significant demand for enhanced quality care for the patients, need for cost reduction by the hospitals, etc. will contribute to the market growth over the forecast period. The company, Infinx, recently announced that the new update of iBridge, its cloud-based patient access will be formally unveiled during their appearance at the upcoming 2017 conference of the Healthcare Financial Management Association (HFMA), a non-profit membership organization for healthcare financial management executives. This new technology will boost competition among the market players and hence will fuel the growth of the market.

North America holds the largest share in the market due to certain factors such as rise in healthcare expenditure, technological innovations, funding and training initiatives, and government support for patient flow management solutions. Whereas, Europe is the second leading market after North America in terms of revenue contribution. The market growth in Europe is attributed to increase in awareness among people, growth in healthcare facilities, and huge patient pool, among others.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/730

Patient Flow Management Solutions Market Players

Major players in the market are, Cerner Corporation, Infinx, Medworxx Solutions, Inc., Mckesson Corporation, Teletracking Technologies, Inc., Aptean, Stanley Healthcare, Getinge Group, Awarepoint Corporation, Central Logic, Inc., Allscripts Healthcare Solutions, Inc., STANLEY Healthcare, Care Logistics LLC, Guard RFID Solutions Inc., Intelligent Insites, Inc., GRM Information Management Services, Inc., and Epic Systems Corporation.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Gumboro Disease Market Size , Share and Forecast till 2025

3:44 pm 3 October 2017

Gumboro disease also called as Infectious bursal disease (IBD) is a viral disease caused by Infectious Bursal Disease Virus (IBDV), which mostly targets the immune system of chickens. This disease was first observed in area Gumboro of Delaware, U.S.A., so called as Gumboro disease. It can be seen in turkeys and ducks without immunosuppression. It is a highly contagious disease occurring in chickens older than 3 weeks. Infected chicken may have the symptoms such staining of feathers around the vent with feces and several urates, ruffled feathers, anorexia dehydration in the pectoral, thigh and abdominal muscles, and impaired kidneys by chronic urate diathesis. Subclinical infection might results in deficiency in immunological response to Infectious Bronchitis, Newcastle disease, Marek’s disease, and susceptibility to gangrenous dermatitis and Inclusion Body Hepatitis. Supplement of multivitamin and facilitating access to water might help in curing the disease, as treatment of this disease is not available. Preventive measures such as vaccination helps in the Gumboro disease.

Request for sample copy of this report : https://www.coherentmarketinsights.com/insight/request-sample/783

High transmission rate of gumboro disease and rising need to prevent it, are the important factors contributing to the growth of gumboro disease market

Increasing prevalence rate of Gumboro disease is affecting the poultry industry drastically. This is a contiguous disease and it is easy to transmit through all the poultry area, as infected chickens sheds the infection in their feces resulting in to the loss of poultry business. Treatment requirement for Gumboro disease to reduce loss is driving the growth of Gumboro disease market. According to the data published by Science Alert in 2013, economic loss due to Gumboro disease in Nigeria for 2009, 2010, and 2011 accounted for more than 3 billion Nigerian currency. According to the data published by Centre d’etudes et de Recherché, Belgium in 2000, the mortality rate due to Gumboro disease in the U.S. was 5% whereas in Japan and Europe the rate is high 50% to 60% in laying hens and 25% to 30% in broilers.

However, increase in research and developments with new vaccines in the pipeline for the prevention from Gumboro disease is expected to propel the Gumboro disease market. For instance, the Transmune IBD vaccines available by CEVA manufacturers has proven effective for Gumboro disease.

New vaccine development and their effective results are accounting for the larger share of vaccine segment in gumboro disease market

The global gumboro disease market is segmented by species type, by vaccines type and by region

On the basis of species type, the Gumboro Disease Market is segmented into:

Broilers

layers

On the basis of vaccines type, the Gumboro disease market is segmented into:

conventional vaccines

antibody/ antigen complex vaccines

vectored vaccines

High rate of chicken consumers in North America is the driving factor for gumboro disease market in this region

Regional segmentation of Gumboro Disease Market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the major share in the Gumboro disease market due to the high prevalence of gumboro disease and increasing investment in the research and development. The U.S. is the largest broiler chicken industry in the world. According to National Chicken Council, in 2015, there was around 9 billion production of broiler chicken in the U.S. The chicken consumers are more in this region than any other regions in world, so the chances of poultry industry getting affected by Gumboro disease and loss caused by it is more in America, which is driving the growth of gumboro disease market in North America.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/783

Rapid development in the field of vaccinology and novel biotechnology tools are helping the industry players to progress in the gumboro disease market

Key industry players operating the Gumboro Disease Market includes Ceva, ROMVAC Company SA, PTSanbe Farma, Jiangyin Caina Technology co. limited, Cios Co., Salfarm Danmark A/s., Vetbiochem, and others. Growing research and development in the vaccine technology field and increase in rate of gumboro disease is encouraging the vaccine manufacturers to invest in gumboro disease market. Rapid development in the area of immunology, animal science, and biotechnology is giving rise to new biotechnology tools for helping the industry players to sustain in the gumboro disease market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

mHealth Market – Global Industry Insights and Forecast till 2025

1:46 pm 3 October 2017

mHealth Market Overview :

mHealth stands for mobile health is the sub segment of eHealth that deals with the medicinal practice in favor of public health care, supported by mobile devices. The term mHealth is used to refer the use of mobile communication devices such as mobile phones, electronic tablets, PDAs and also comprises of wearable devices such as a smart watch for data collection and information about health care services. mHealth is applicable in wide areas, ranging from collection of community and clinical health data and delivery of healthcare information to medical personnel to real time monitoring of the patient by provision of direct care. In developed countries the patients and consumers extensively use mobile gadgets to search for healthcare services and access various kinds of healthcare information. Doctors, physicians and even nurses are found making use of mobile devices to access information about a patient from established databases and other resources. The mHealth market comprises of devices such as ECG monitors, blood glucose meters, multi parameter trackers, sleep apnea trackers, etc.

Request a sample pdf Copy of report @ https://www.coherentmarketinsights.com/insight/request-sample/749

Robust penetration of smartphones in the developed as well as developing countries responsible to boost global mHealth market

According to World Health Organization (WHO), 112 member states participated in the module of survey, out of which 83% were reported to possess at least one mHealth initiative in their country. A majority of these member states reported implementation of 4 or more types of mHealth initiatives. As per the mHealthShare factsheet, 62% of smartphone owners in the U.S. have used their phone in 2014 to look up for health condition and information as compared to that of 52% in 2012. The rising interest and extensive use of mobile devices including tablets are widening the scope of global mHealth market.

The global mHealth market is segmented on the basis of equipment, service, therapeutics and geography.

On the basis of equipment, the global mHealth market is segmented as

Blood Glucose Meters

BP Monitors

Pulse Oximeters

Neurological Monitoring

Cardiac Monitors

Apnea and Sleep Monitor

Wearable fitness sensor device and Heart Rate Meters

Others

Based on the service type, the global mHealth market is segmented as

Wellness Service Market

Prevention Services Market

Treatment Services Market

Diagnosis Service Market

Monitoring Services Market

Healthcare Systems Strengthening Solutions Market

Based on the therapeutic segment, the global mHealth market is segmented as

Cardiovascular

Diabetes

Respiratory

Neurology

Others

Asia Pacific is expected to show an accelerating global mhealth market mainly due to government initiatives in spreading healthcare awareness

On the basis of geography, the global mHealth market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. The mHealth market is spurred in the North America attributing to flourishing number of pilot projects and live health in the U.S. and Canada. The increase in number of wellness apps coupled with rising adoption of smartphones as well as increasing reliability on mobile phone apps for day to day routine is expected to accelerate the regional market in the coming forecast years. Further, rise in the rural population in countries such as Vietnam, Indonesia and India are also diligently involved in expansion of global mHealth market. Certain solutions such as bulk messaging to inform disease spread and awareness tips are commonly used in these countries. Use of local language to compose these text messages effectively helps in delivering the information to the rural population. Indian government has launched an official application named National Health Portal, India that is designed in a way to provide access and information about healthcare to a predominantly semi- literate or illiterate population.

Factors responsible to boost the mHealth market involves rising awareness among people regarding regular health updates

The primary factor responsible to drive the global mHealth market is the affordability and integration of wireless technologies which can cause a breakthrough in monitoring and diagnostics, mainly in the developing countries where smartphones are penetrating the market at a great speed. The rapid rise in the incidence of the chronic diseases as well as the advancing technologies in the mobile health apps that delivers information of personal healthcare on the regular basis are also responsible to fuel mHealth market. For instance, the in- build health app in the Apple phones provides insights about the activity, sleep, nutrition, everyday workout and even maintains reproductive health acting a smart assistant for the mobile phone users. Moreover, the mHealth devices such as glucometers and oximeters are applicable in the geriatric population of monitoring blood glucose levels and oxygen levels mainly in the diabetic population. However, lack of accuracy of these devices could restrain the market growth as many people complain about the extreme results displayed by these devices.

Get discount on this report @ https://www.coherentmarketinsights.com/insight/request-discount/749

The key players involved in improvement of the mHealth devices to increase sales in the global mHealth market

The key players operating the mHealth market are Medtronic Inc., Apple Inc., Sanofi, Mobistante, Inc., AirStrip Technologies, Inc., AliveCor, Inc., LifeWatch AG, Koninklijke Philips N.V, Jawbone, Nike, Inc., Omron Corporation, Johnson and Johnson, Bio Telemetry Inc., Withings, AgaMatrix Inc., iHealth Lab Inc., Qualcomm, AT&T, Cerner Corporation and Cisco Inc. The mobile service provider companies are focusing to deliver uninterrupted healthcare services in the robust penetration of 3G and 4G networks across the world while several other companies manufacturing healthcare related technological devices are focusing towards providing devices with more precision and accuracy to the users by better optimization and improving the sensitivity of these devices.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/

Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

https://www.coherentmarketinsights.com/market-insight/infusion-pumps-market-127

The global infusion pumps market was valued at US$ 2,985.5 million in 2015 and is expected to witness a moderate CAGR of 6.0%

12:17 pm 3 October 2017

The Global Infusion Pumps Market was valued at US$ 2,985.5 million in 2015 and is projected to expand at a CAGR of 6.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Increasing number of applications of infusion pumps in the healthcare sector is projected to support growth of the infusion pumps market over the forecast period.

Infusion pump delivers controlled amount of fluid and medications into the bloodstream over a period of time. The drug infusion system includes two components, namely open loop and closed loop. According to a study by Healthcare Human Factors University Health Network, in 2009, around 13% of the hospitals in Ontario used smart pumps and around 6% were in the process of implementing the techniques. Thus, adoption rate of smart large volumetric infusion pumps in Ontario has been low. Infusion pumps have contributed to improvements in patient care at affordable costs. Apart from its wide application in hospitals and for clinical use, the systems are also used in the form of portable device to provide the drug or fluid on the move. Furthermore, the major application that has revolutionized the use of infusion pumps involves diabetes where it works as an insulin pump to provide with the controlled and preset amount of insulin in the patient’s body. According to the fact sheet by W.H.O, number of diabetic patients witness a steep increase from 108 million in 1980 to 422 million in 2014. This in turn is expected to favor the market growth for infusion pumps over the forecast period.

To know the latest trends and insights prevalent in the infusion pumps market, click the link below:

The development of combination in medical device technology and advanced drugs are the precursor for adoption of control infusion therapies, which have increased the use of infusion pumps globally. Currently, there are various clinical applications of infusion pumps that involves life-sustaining along with life-saving treatments under other clinical segments such as anesthesia, intensive care, and oncology. Infusion pumps are used in various settings such as wards, home care environment and hospitals for pain management and other drug related treatments. Furthermore, rapid development of the healthcare infrastructure in emerging economies and upgrade of the same in developed regions creates a highly conducive environment for growth of the infusion pumps market in the near future.

Major players in the global infusion pumps market are laying emphasis on product development, upgrading existing devices, and geographical expansions through various strategic mergers and acquisitions. For instance, in 2015, InfuSystem Holdings, Inc. –an infusion pumps provider and related healthcare services in the U.S. and Canada –acquired Ciscura Holding Company, Inc. – a provider of ambulatory infusion pumps and healthcare services to medical facilities. Also, in 2016, ICU Medical Inc. – a developer and manufacturer of medical devices specific in the areas of vascular therapy, oncology and critical care applications – acquired Hospira Infusion Systems business from Pfizer Inc. for a total value of US$1 billion in cash and stock.

Get an exclusive discount on this report :

https://www.coherentmarketinsights.com/insight/request-discount/127

Key takeaways of the market:

The global infusion pumps market is expected to expand at a CAGR of 6.0% during the forecast period (2016–2024). Rising prevalence of diabetes across the globe is expected to favor the infusion pumps market growth over the forecast period.

The analgesia application segment in the global infusion pumps market was estimated to be the largest in 2015 and is expected to retain its dominance in the market throughout the forecast period in terms of value. Increasing prevalence for chronic pain globally is expected to favor the growth for infusion pumps market in the near future. According to British journal of anesthesia, in 2013, around 20% of the European population was suffering from chronic pain.

In terms of product type, the insulin product type segment is expected to expand at a significant CAGR of 6.9% during the forecast period, owing to rise in population suffering from diabetes globally

The global infusion pumps market is characterized by strategic research and development and advancements in the technology of various medical devices including the continuous glucose monitoring device and infusion pumps.

Some of the major players in the global infusion pumps market include Medtronic Plc., ICU Medical Inc., Johnson & Johnson Private Ltd., Braun Melsungen AG., Smiths Medical, CareFusion Corporation, Baxter International Inc., Fresenius Kabi AG, MOOG Inc., Terumo Corporation, Nipro Corporation and Codman & Shurtleff, Inc., Infusystem

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Raj Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Intraocular Lens Market Report 2017–2025 | Industry Trends and Analysis

1:43 pm 30 September 2017

Intraocular Lens Market Overview :

Intraocular lens is a minute artificial lens used to replace the eye’s natural lens that is removed during the cataract surgery, this lens is called as an intraocular lens (IOL). A person with cataract has a cloudy lens. Things look less colorful, blurry, and hazy with a cataract, which is a leading cause of blindness globally. Intraocular lenses are also used for refractive lens exchange, which is a vision correction surgery. When the intraocular lens were not in use, a patient whose cataract has removed, had to wear a very thick eyeglass or special contact lenses in order to see after the cataract surgery. A variety of intraocular lenses are available and person can choose the best lens according to his lifestyle or specific visual need. Various premium intraocular lenses have been approved by U.S. Food and Drug Administration (FDA) for use by cataract surgeons. This premium lenses has advantage over single vision intraocular lens that are covered with Medicare and other types of healthcare insurance.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/690

Rising incidence of ophthalmic and ocular conditions driving the intraocular lens market

The major factors which are driving the intraocular lens market includes increasing incidence of ophthalmic and ocular conditions, risk of cataract among diabetic patients. According to World Health Organization (WHO) in 2010 the total number of persons with visual impairment was estimated to be 285 million, including 39 million blind people among those 80% were above age of 50. Another factor which is driving the intraocular lens market is risk of ocular complications among the diabetic patients. For instance, the data published by International Diabetic Federation in 2011 showed that diabetes affects more than 240 million people worldwide which can lead to ocular complications such as diabetic retinopathy, cataract, diabetic papillopathy, glaucoma and ocular surface disease. Introduction of technologically advanced products such as accommodative multifocal intraocular lenses, preference shift from conventional intraocular lenses to foldable lenses, increasing government initiatives and rising adoption for premium intraocular lenses are expected to boost growth of the intraocular lens market.

However, high cost, lack of reimbursement and post-operative complications such as refractive errors are some factors that are hindering the growth of intraocular lens market. The opportunities for global intraocular lens market include availability of advance technologies of micro-incision cataract surgery and femtosecond lasers and multi-distance vision capabilities is a global trend for intraocular lens market.

The pseudophakic intraocular lens is the most commonly used intraocular lens in a cataract surgery

The global intraocular lens market segments by material, by product type, by end user and by region

On the basis of material, intraocular lens market is segmented into

Polymethylmethacrylate (PMMA)

Silicone

Hydrophobic acrylic

On the basis of product type, intraocular lens market is segmented into

Premium Intraocular Lens

Multifocal Intraocular lens

Accommodating Intraocular lens

Toric Intraocular lens

Phakic Intraocular lens

Aspheric Intraocular lens

Blue light filtering Intraocular lens

Monofocal Intraocular Lens

On the basis of end user, the intraocular lens market is segmented into

Hospitals

Ambulatory Surgical Centers

Eye Research Institutes

Ophthalmology clinics

The increase in population with the need of vision correction surgery is expected to propel the growth of intraocular lens market in North America

Regional segmentation of intraocular lens market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Africa, and Middle East. North America dominates in the intraocular lens market owing to factors such as geriatric population, affluence of the American baby boomer generation and the ability of surgeons to bill for premium refractive outcome. According to data provided by Vision Council in 2015, around 76.2% adults had vision correction surgery in the U.S., this factors are contributing to the growth of the intraocular lens market. Asia Pacific is another region which has large share in the intraocular lens market. Factors such as government initiatives and awareness to avoid the blindness, are expected to fuel the growth of intraocular lens market in Asia Pacific.

Get discount on this report : https://www.coherentmarketinsights.com/insight/request-discount/690

The highly competitive intraocular lens market is subject to change to the technological advancement and industry standards

Key players operating the global intraocular lens market are Abbott medical Optics Inc., Alcon Inc., Rayner Intraocular lenses limited, Eyekon Medical, Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Lenstec, HumanOptics AG, STAAR Surgical Company and Hoya Corporation. The intraocular lens industry is highly competitive and there should be changes according to technological advancement and evolving industry requirements and standards. The competition among the industry players is based on the factors such as technological leadership and innovation, quality and efficacy of the products, relationships with eye care professionals and healthcare providers, pricing, and breadth and depth of product offering.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Gumboro Disease Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

5:07 pm 29 September 2017

Gumboro disease also called as Infectious bursal disease (IBD) is a viral disease caused by Infectious Bursal Disease Virus (IBDV), which mostly targets the immune system of chickens. This disease was first observed in area Gumboro of Delaware, U.S.A., so called as Gumboro disease. It can be seen in turkeys and ducks without immunosuppression. It is a highly contagious disease occurring in chickens older than 3 weeks. Infected chicken may have the symptoms such staining of feathers around the vent with feces and several urates, ruffled feathers, anorexia dehydration in the pectoral, thigh and abdominal muscles, and impaired kidneys by chronic urate diathesis. Subclinical infection might results in deficiency in immunological response to Infectious Bronchitis, Newcastle disease, Marek’s disease, and susceptibility to gangrenous dermatitis and Inclusion Body Hepatitis. Supplement of multivitamin and facilitating access to water might help in curing the disease, as treatment of this disease is not available. Preventive measures such as vaccination helps in the Gumboro disease.

Request for sample copy of this report : https://www.coherentmarketinsights.com/insight/request-sample/783

High transmission rate of gumboro disease and rising need to prevent it, are the important factors contributing to the growth of gumboro disease market

Increasing prevalence rate of Gumboro disease is affecting the poultry industry drastically. This is a contiguous disease and it is easy to transmit through all the poultry area, as infected chickens sheds the infection in their feces resulting in to the loss of poultry business. Treatment requirement for Gumboro disease to reduce loss is driving the growth of Gumboro disease market. According to the data published by Science Alert in 2013, economic loss due to Gumboro disease in Nigeria for 2009, 2010, and 2011 accounted for more than 3 billion Nigerian currency. According to the data published by Centre d’etudes et de Recherché, Belgium in 2000, the mortality rate due to Gumboro disease in the U.S. was 5% whereas in Japan and Europe the rate is high 50% to 60% in laying hens and 25% to 30% in broilers.

However, increase in research and developments with new vaccines in the pipeline for the prevention from Gumboro disease is expected to propel the Gumboro disease market. For instance, the Transmune IBD vaccines available by CEVA manufacturers has proven effective for Gumboro disease.

New vaccine development and their effective results are accounting for the larger share of vaccine segment in gumboro disease market

The global gumboro disease market is segmented by species type, by vaccines type and by region

On the basis of species type, the Gumboro Disease Market is segmented into:

Broilers

layers

On the basis of vaccines type, the Gumboro disease market is segmented into:

conventional vaccines

antibody/ antigen complex vaccines

vectored vaccines

High rate of chicken consumers in North America is the driving factor for gumboro disease market in this region

Regional segmentation of Gumboro Disease Market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the major share in the Gumboro disease market due to the high prevalence of gumboro disease and increasing investment in the research and development. The U.S. is the largest broiler chicken industry in the world. According to National Chicken Council, in 2015, there was around 9 billion production of broiler chicken in the U.S. The chicken consumers are more in this region than any other regions in world, so the chances of poultry industry getting affected by Gumboro disease and loss caused by it is more in America, which is driving the growth of gumboro disease market in North America.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/783

Rapid development in the field of vaccinology and novel biotechnology tools are helping the industry players to progress in the gumboro disease market

Key industry players operating the Gumboro Disease Market includes Ceva, ROMVAC Company SA, PTSanbe Farma, Jiangyin Caina Technology co. limited, Cios Co., Salfarm Danmark A/s., Vetbiochem, and others. Growing research and development in the vaccine technology field and increase in rate of gumboro disease is encouraging the vaccine manufacturers to invest in gumboro disease market. Rapid development in the area of immunology, animal science, and biotechnology is giving rise to new biotechnology tools for helping the industry players to sustain in the gumboro disease market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Rheumatology Therapeutics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

4:03 pm 29 September 2017

Rheumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to rheumatology diseases. Osteoarthritis, ankylosing spondylitis, rheumatoid arthritis, gout, psoriatic arthritis, reactive arthritis, fibromyalgia, and scleroderma are some of the common types of rheumatology diseases. Rheumatology treatment involves medications, exercises, and physical therapies with surgical treatment to cure joint damage. Early treatment can be beneficial for treatment of rheumatologic symptoms. Physicians prescribe disease-modifying antirheumatic drugs (DMARD’s) for the treatment of rheumatologic disease. Sufficient nutrition, proper exercise, and medications can help to cure rheumatology diseases.

Request for sample copy of this report : https://www.coherentmarketinsights.com/insight/request-sample/796

Increasing burden of rheumatology diseases globally is propelling the growth of rheumatology therapeutics market

The increase in population with some sort of rheumatology arthritis globally is major driving factor for the rheumatology therapeutics market. According to data given by Centers for Disease Control and Prevention (CDC) in 2013, around 52.5 million of adults in the U.S. have suffered from rheumatology arthritis, which equals to 23% of the population with 1% being the prevalence rate of rheumatology diseases globally. According to the Global Burden of Disease 2010 study data, prevalence rate for knee arthritis globally was 3.8% and for hip osteoarthritis was 0.85% globally. Additionally, technological advancements in medical field, investments in the healthcare sector over research and development, and rising trend of fitness are important factors contributing to the growth of rheumatology therapeutics market. According to the World Health Organization (WHO) in 2014, government spent 15.5% on healthcare sector.

However, introduction of biosimilars is major restraint for rheumatology therapeutics market. Increasing demand for biosimilar may hinder the conventional drug commonly used for rheumatology diseases treatment. Patent expiry of some drugs used in the treatment of rheumatology diseases is also hampering the growth of rheumatology therapeutics market. For instance, patent expiry of Enbrels drug in 2012.

Rheumatoid arthritis holds the largest share due to high prevalence rate in the rheumatology therapeutics market

The global rheumatology therapeutics market is segmented by disease type, by drug type, by end user, and by region

On the basis of disease type, the rheumatology therapeutics market is segmented into:

Osteoarthritis

Ankylosing spondylitis

Rheumatoid arthritis

Gout

Psoriatic arthritis

Reactive arthritis

Fibromyalgia

Scleroderma

Others

On the basis of drug type, the rheumatology therapeutics market is segmented into:

Disease Modifying Antirheumatic Drugs (DMAD’s)

Humira

Remicade

Cyclosporine

Methotrexate

Biologics

Tofacitinib

Others

On the basis of end user, the rheumatology therapeutics market is segmented into:

Hospitals

Medical clinics

Established healthcare sector of North America is contributing to the leading position of this region in rheumatology therapeutics market

Regional segmentation of rheumatology therapeutics market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominates rheumatology therapeutics market, owing to increasing population with rheumatology diseases, changing lifestyle, and established medical and healthcare sector. According to Centers for Disease Control and Prevention (CDC), around 27 million people are suffering with Clinical arthritis in the U.S, around 8 million people with Gout syndrome, and 78 million adults are at risk to suffer from clinical arthritis till 2040. Asia Pacific is expected to witness the growth in the rheumatology therapeutics market due to increase in patient population and developing healthcare sector.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/796

The key players are involved in doing licensing agreement with other manufacturers to hold the major market share in rheumatology therapeutics market

Key industry players operating the rheumatology therapeutics market includes AstraZeneca, Rigel pharma, Abbott Laboratories, Pfizer, Amgen, Janssen Biotech, Merck Co. Inc., Eli Lily, and Alder Biopharmaceuticals. Key players are involved in the acquisitions and agreement with other companies to hold the maximum share. For instance, licensing agreement of Bri Stol-Myers Squibb with Alder Biopharmaceuticals Company and the major acquisition of Ardea Biosciences by AstraZeneca are one of the important agreements between 2007 and 2012.

AboutCoherent Market Insights:

CoherentMarket Insights is a prominent market research and consulting firmoffering action-ready syndicated research reports, custom marketanalysis, consulting services, and competitive analysis throughvarious recommendations related to emerging market trends,technologies, and potential absolute dollar opportunity.

ContactUs:

Mr.Shah

CoherentMarket Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel:+1–206–701–6702

Novel Drug Delivery System (NDDS) Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

2:40 pm 29 September 2017

Novel Drug Delivery System (NDDS) refers to the formulations, systems to transport pharmaceutical compound in the body, and approaches needed to achieve the desired therapeutic effect. The side effects and slow processing of conventional drug therapy are contributing to the emergence of novel drug delivery system’s concept. Novel ideas based on interdisciplinary approaches controlling the pharmacodynamics, immunogenicity, pharmacokinetics, bio-recognition, and efficiency of drugs were generated. This new system helps in reducing the drug degradation, increasing availability of drugs, and prevent from harmful side effects of drugs. This system provides various commercial and therapeutic benefits by enabling to formulate the novel drug delivery devices so that it can incorporate the drug molecules into the new delivery system.

Request for sample copy of this report : https://www.coherentmarketinsights.com/insight/request-sample/801

Increasing use of novel drug delivery system in cancer therapy is driving the market

Growing prevalence of chronic diseases, drug innovation, and the rising biologics market is also contributing to the growth of novel drug delivery systems market. According to data published by Fraser Institute Canada in July 2016, around 22% of overall sales of pharmaceutical firms in 2013 and expected to reach 32% by 2023 globally. The global spending on biologics has increased by 7% as compared to previous year.

Effectiveness of novel drug delivery system in cancer therapy is also a major factor propelling the novel drug delivery systems market growth. For instance, according to the data published by International Journal of Pharma Sciences and Research (IJPSR), around 9 million deaths occurred due to cancer in 2015 and estimations reveal that around 11.4 million people are expected to die due to cancer by 2030. However, patent cliff, patent expiry, and an increase in injury cases are the factors hindering the growth of global novel drug delivery systems market.

The efficacy of nanoparticles in therapeutics is accounting for the dominance of this segment in novel drug delivery system market

The global novel drug delivery system (NDDS) market is segmented by route of administration type, carrier type, and end user.

On the basis of route of administration type, the novel drug delivery system (NDDS) market is segmented into

Injectable

Oral

Pulmonary

Transdermal

others

On the basis of carrier type, the novel drug delivery system (NDDS) market is segmented into

Nanoparticles

Liposomes

Microspheres

Monoclonal antibodies

others

On the basis of end user, the novel drug delivery systems market is segmented into

Hospitals

Medical research centers

Cancer treatment centers

others

Increase in investment in research and development for new medicines is accounting for the growth of novel drug delivery systems market in North America

Regional segmentation of novel drug delivery system (NDDS) market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. North America holds the major share in the novel drug delivery systems market owing to the factors such as growing research and development in the field of drug delivery systems, the high adoption rate of new technology, and supportive reimbursement policies. According to Pharmaceutical Research and Manufacturers of America (PhRMA), the members of PhRMA have invested an estimated amount of $51.2 billion in 2014 in research and development of novel medicines. Asia Pacific is also expected to witness growth in the novel drug delivery systems market due to the increase in investment in pharmaceutical and biotechnology Industry and growing research and development in the healthcare sector.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/801

Key industry players are adopting strategy such as geographical expansion and agreement with other companies to hold the lead in the novel drug delivery system market

Key industry players operating the novel drug delivery system (NDDS) market include Abbott Laboratories Limited, Johnson & Johnson, 3M Company, Bayer AG, Novartis AG, Teva Pharmaceuticals Industries Limited, Boston Scientific, AstraZeneca Plc., Sanofi SA, and Genzyme Co.. The key industry players are involved in applying strategies such as geographical expansion, low-cost strategy, agreement with other companies, and penetration strategy to hold the largest share in the highly competitive novel drug delivery systems market. For instance, Vetter Pharmaceutical and Microdermics Inc. have done strategic corporation agreement recently with each other to develop innovative micro needle drug delivery system.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Ocular Surgery Market to Surge Past US$ 2.6 Billion by 2025 Due to Growing Aging Population

12:58 pm 29 September 2017

The Global Ocular Surgery Market by device type (Cataract surgery devices, Glaucoma surgery devices, and Vitrectomy surgery devices) and region was valued at US$ 1,517.5 million in 2017 and is projected to exhibit a CAGR of 7.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Growing aging population and high incidence rate of diabetes coupled with technological advancement are drivers fueling growth of the ocular surgery market.

Rise in number of cataract and glaucoma surgeries provide lucrative opportunities for growth of the global ocular surgery market. Increasing aging population globally is expected to fuel growth of the ocular surgery market. According to World Health Organization (WHO), in 2010, around 285 million people were recorded to be suffering from visual impairment, which included 39 million blind people, of which 80% were 50 years of age and above. Cataract surgery segment is expected to grow at a rapid rate, which in turn, is expected to favor growth of the ocular surgery market in near future. High occurrence rate of diabetes, exposure to ultraviolet sunlight, and family medical history are some of the various factors expected to boost growth of the global market. According to the International Diabetes Federation, in 2010, around 285 million people were affected by diabetes mellitus, which signifies a high risk of glaucoma and cataract among these people.

Request for sample copy of Ocular Surgery Market : https://www.coherentmarketinsights.com/insight/request-sample/826

Browse 50 Market Data Tables and 25 Figures spread through 170 Pages and an in-depth TOC on ‘Ocular Surgery Market by Procedure (Cataract surgery, Glaucoma surgery, and Vitrectomy), Device type (Cataract surgery devices, Glaucoma surgery devices, and Vitrectomy surgery devices) and Region - Global Forecast to 2025’

Development of technologically advanced ocular devices, including femtosecond laser cataract surgery technology and intraocular lenses (IOLs), such as Toric IOLs, reduce dependency on glasses or contact lenses post-surgery. In 2016, Allergan received FDA-clearance for the XEN Gel Stent, a new surgical treatment that reduces intraocular pressure for patients with refractory glaucoma. Xen Gel stent is an effective alternative to conventional surgeries such as Trabeculectomy. Technological advancements are thus, creating less painful and time-efficient procedures, which in turn, is improving surgery outcomes in an effective, safe, and predictable manner.

Asia Pacific and Africa are expected to witness maximum growth in the global ocular surgery market, owing to rapid increase in aging population in these region. According to NCBI, 2010, around 11.2 million people 40 years of age and above suffered from glaucoma, in India; while in Australia, in 2016, around 1 in 30 people were hospitalized due to eye-related problems.

According to American Academy of Ophthalmology, in 2015, Africa was highly affected by glaucoma, with the highest prevalence of Primary Open Angle Glaucoma (POAG) in African countries and is expected to experience meteoric growth over the forecast period.

Get discount on this report : https://www.coherentmarketinsights.com/insight/request-discount/826

Key takeaways of the market:

The global ocular surgery market is expected to exhibit a CAGR of 7.2% over the forecast period (2017–2025), due rampant growth in precursor diseases such as diabetes

Among device types, the cataract surgery devices segment holds a dominant position, as cataracts remain the leading cause of blindness. According to World Health Organization (WHO), in 2014, 47.8% of blindness, globally, was caused by cataracts.

Some of the major players involved in global ocular surgery market are Johnson & Johnson Vision Care Inc., Alcon, Carl Zeiss, Meditec, Bausch & Lomb, Ellex Medical Lasers, Topcon Medical Systems, Dutch Ophthalmic Research Center (International) B.V. (DORC), and Lumenis.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Global Vitamins Market to Surpass US$ 7.95 Billion by 2025

4:48 pm 28 September 2017

The Global Vitamins Market was valued at US$ 5.16 billion in 2016, according to a new report published by Coherent Market Insights. Vitamins are organic substances that are required by the body in small amounts, for proper growth and development. These are usually extracted naturally from certain food and is an essential component of diet. However, inadequate intake of vitamins in the diet may led to certain deficiency diseases, such as avitaminosis. North America dominated the global vitamins market during the last five years and is expected to retain its dominance in the market throughout the forecast period, due to growing consumer preferences for healthy diet coupled with increasing awareness for various vitamins deficiency diseases. Pharmaceuticals is the largest and the fastest growing segment amassmong end use industry segments for vitamins market. For instance, India Brand Equity Foundation (IBEF)—a Trust established by the Department of Commerce, Ministry of Commerce and Industry, Government of India—the overall Indian healthcare market was valued at US$ 100 billion in 2016 and is expected to grow to US$ 280 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 22.9%. The growing end use industry such as pharmaceuticals, personal care, food & beverages and animal feed is propelling the market for vitamins during the forecast period. Pharmaceuticals followed by animal feed and personal care is dominating the market in 2016 and the trend is expected to remain the same from 2017 to 2025.

Request for sample copy of Vitamins Market : https://goo.gl/vcVa3K

Vitamins are classified into two types, water soluble and fat soluble. Water soluble vitamins (vitamin B-complex group and vitamin C), are easily dissolve in water and can be absorbed by the body. However, these vitamins are not stored in the body and excreted as urine, so a continuous supply is required in our everyday diet. Fat soluble vitamins (A, D, E, K), are dissolved in fat prior to being absorbed into the bloodstream. Excess intake of these vitamins are stored as fats in the liver and fat tissue. According to Coherent Market Insights, the vitamin B, is the dominant segment among product types in the global vitamin market. Whereas, vitamin E is the fastest growing segments in the product type segment and is expected to grow at a CAGR of 5.06% during the forecast period. A vast majority of the global population is at risk of vitamin deficiency related diseases. Various global organizations and governments are continuously focusing on addressing this situation.

On 2012, according to World Health Organization (WHO), an estimated 250 million preschool children are vitamin A deficient and it is likely that in vitamin A deficient areas a substantial proportion of pregnant women is vitamin A deficient. Also, an estimated 250 000 to 500 000 vitamin A-deficient children become blind every year, half of them dying within 12 months of losing their sight.

UNICEF-supported Vitamin A supplementation programs have been reaching out to children aged 6 to 59 months in priority countries for nearly two decades

Get discount on Vitamins Market : https://goo.gl/JykfdY

Key takeaways of the market:

Asia-Pacific is projected to be the lucrative region in global vitamins market. It accounted for around 27.6% of overall vitamins market revenue in 2016. The market in this region is expected to be primarily driven by rampant growth of end-use industries in China, India, and ASEAN countries. The growing demand for improved food supplements, rising urbanization, growing economy are some of the key drivers for the growth of vitamins in the Asia-Pacific region.

The market in Latin America is expected to register a significant growth rate over the forecast period. Rise in discretionary income along with increasing food & beverages industry are expected to create lucrative growth opportunities for the players in this region.

The mass merchandisers is dominating the market for distribution channel segments in the global vitamins market during the projected period.

Adisseo France S.A.S., Archer Daniels Midland Co., BASF SE, CSPC Pharmaceuticals Group Limited, Lonza Group Ltd., North China Pharmaceuticals Corporation, Pharmavite LLC, Zhejiang Hangzhou Xinfu Pharmaceutical Co. Ltd. are few of the key players in global vitamins market.

There are various organic, and inorganic growth strategies which are being followed by the leading market players in the market. Technological advancement is leading to the key innovation in the new product launches. Companies are also investing in expansions, mergers & acquisitions, and joint ventures in the market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Aptamers Market to Surge Past US$ 10,407 Million by 2025 due to Widened Application Area

1:50 pm 28 September 2017

The Global Aptamers Market was valued at US$ 2,304.7 million in 2016 and is projected to expand at a CAGR of 18.4% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Technological advancements, increasing healthcare expenditure by governments, rising prevalence of lifestyle related diseases projected to have a meteoric growth of the aptamers market over the forecast period.

Numerous advantage of aptamers over antibodies provides a lucrative growth of the global aptamers market. Aptamers have been identified for potential therapeutic and diagnostic purposes, which gain the interest of the scientists within basic and clinical sciences to detect, analyze and quantify these small molecules for further discoveries and is expected to fuel the growth of aptamers market. Aptamer products can also be used as biosensors to act on proteins for biomedical diagnostic applications. This is expected to be a key growth segment in the market in the near future. Furthermore, clinical trials undertaken in aptamer development by various companies would be extremely useful to pharmaceutical industry to discover and develop new drugs.

Request for sample copy of report : https://www.coherentmarketinsights.com/insight/request-sample/774

Many manufacturers are focusing on obtaining aptamers with sufficiently high binding affinities for various kinds of diseases. In September 2015, NeoNeuro has been granted support from BPIfrance Financement under the PIA-1 program for the use of aptamers as a diagnostic and therapeutic tools in Alzheimer’s disease.

Various healthcare companies are actively investing in furthering clinical trials of aptamers in novel applications, which in turn would significantly enhance market growth.

Markets such as Japan, China, Brazil, and India are largely untapped are expected to grow over the forecast period, owing to growing demand for cost effective therapeutics and initiatives taken by key players to expand and increase product distribution to capitalize on highly lucrative growth opportunities in these countries. A technology shift has been observed in the global healthcare sector, with manufacturers focusing on highly advanced techniques for the isolation of high affinity and high selectivity aptamers. For instance, the collaboration of Siva Therapeutics with SomaLogic, Inc., in March 2014, to assess the ability of Somalogic’s SOMAmers to target gold nanorods in cell-based assays will promise to shed light on basic science as well as new product potential about the dynamics of targeting nanorods with aptamers.

Get discount on this report : https://www.coherentmarketinsights.com/insight/request-discount/774

Key takeaways of the Aptamers Market:

The global aptamers market is expected to expand at a CAGR of 18.4% during the forecast period (2017–2025) as there exists major market potential, especially in Asia Pacific, Latin America, Middle East, and Africa.

Nucleic acid aptamers is mainly used as a substitute for protein-based targeting approaches, owing to better chemical stability and thermodynamic compared to peptide therapeutics

Diagnostics is the major application of aptamers, as it is widely used for molecular imaging, biomarker discovery, drug discovery, and other diagnostic purposes

Some of the major players involved in global aptamers market are Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, SomaLogic, Inc., NeoNeuro SAS, Aptagen.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/

Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

Neurorehabilitation Devices Market – Global Industry Insights and Forecast upto 2025

12:33 pm 28 September 2017

Neurorehabilitation Devices Market Overview:

Neurorehabilitation is a well-elaborated therapist-supervised medical procedure, which aims at recovering a nervous system injury resulting from non-functional to functional nervous system and improving the well-being of a person. World health organization (WHO) survey of 2014, revealed that each year around 15 million people are affected by neurological disorders, from which around 5 million suffer from permanent disability. The report also revealed that, around 2.5 million people are affected with multiple sclerosis and 10 million with Parkinson’s disease, every year, throughout the world. Increase in the prevalence of neurological diseases among the populace, creates a huge need to introduce neurorehab centers and neurorehabilitation devices to ensure simplification of normal-routine life and decrease patients’ dependability on others.

Request a sample pdf Copy of report @ https://www.coherentmarketinsights.com/insight/request-sample/740

Increase in opportunities and demand for neurorehabilitation devices in the market research industry

Higher incidences of neurological disorders has helped boost the demand for neurorehabilitation devices over the recent years. People’s awareness related to health and the increasing investment in healthcare industry have created a high demand for these devices. According to Centers for Disease Control and Prevention (CDCP) 2015, around 130,000 individuals face fatal strokes every year in the United States. Thus, the increasing need to reduce the incidences of strokes every year, has resulted in the increasing demand for neurorehabilitation devices. Large number of people who are affected by Parkinson’s disease are recorded in regions such as U.S., U.K., Finland, Iceland, and Ireland. These regions extensively employ neurorehabilitation devices, fueling market growth. Additionally, age plays a critical role in increasing the risk of neurological related disease. Thus, regions with higher geriatric populations lend immense opportunities for growth of the neurorehabilitation devices market. Neurorehabilitation devices such as wearable technology, nanotechnology, and robotics, primarily work towards improving the nervous system, in turn reducing disability and increasing ease of daily functioning of individuals.

Higher costs hinders the market growth

The major restraint for the neurorehabilitation devices market growth, is the lack of ease associated to usage of these device and its unaffordability, mainly in emerging economies and low income regions such as the Middle East, Africa, and Latin America. Moreover, unavailability of skilled specialists to handle these devices hampers growth of the global market.

The neurorehabilitation devices market has been segmented on the basis of products, indication, and geography:

On the basis of products, the neurorehabilitation devices market is segmented into:

Wearable Devices

Brain computer Interface

Neurorobotic System

Non-invasive Stimulators

On the basis of indication, the neurorehabilitation devices market is segmented into:

Parkinson’s Disease

Stroke

Traumatic Brain Injury

Cerebral Palsy

On the basis of region, the neurorehabilitation devices market is segmented into : North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Asia pacific region making progressive walk towards neurorehabilitation device market

According to world health organization (WHO) 2016, the North American region was leading the global market for using and forming novel neurorehabilitation devices as this region comprises of a large population suffering from neural diseases. The same reports suggests that North America and Europe together hold around 34% of the share in this global market. However, Asia Pacific is expected to progress towards the leading position in the global market for neurorehabilitation devices over the forecast period. . Moreover, Asia Pacific market is increasing the public awareness and investment in health care.

Get discount on this report @ https://www.coherentmarketinsights.com/insight/request-discount/740

Collaboration of key players to make lucrative developments

The major key players of neurorehabilitation devices market are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, Tyromotion, Agiliad, Bioxtreme Robotics Rehabilitation, St Jude Medical Inc., Alter G Inc., Denecor, Ekso Bionics Holding Inc., Helius, Interactive Motion Technologies, Kinestica, Kinetic Muscles, Medtronic Plc., and Neurostyle. Collaboration of key players helps in creative expansion to increase gainful inventions in the global market. For instance, in Sep 2016, Swiss based Hocoma merged with DIH International, which develops rehabilitation solutions and medication management, Moreover, for distribution of their products across different geographical regions, Ectron Ltd. has collaborated withTyromotion and announced the launch of Tyromotion’s PABLO in 2017. PABLO system is a modern assessment and therapy device for the treatment of the neurological disorders.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Global Ethanol Market To Surpass Us$ 53.1 Billion By 2025, Fuelled By Increased Production Of Renewable Fuels

6:12 pm 27 September 2017

Global ethanol market was valued at US$ 48,734.3 million in 2016 and is expected to register a CAGR of 1.00% to reach US$ 53,105.3 million by 2025. The market was pegged at 27,145.9 million gallons in 2016 and is expected to reach 32,165.3 million gallons by the end of the forecast period, expanding at a CAGR of 1.77%, according to a new report published by Coherent Market Insights.

According to the U.S. Department of Energy, use of high-level ethanol blends such as E85 results in lower emissions, thereby boosting the demand for ethanol. The significant rise in number of automobile vehicles on road has resulted in increased pollution levels, which is a concern for governments all over the world. Ethanol can be used as an alternative fuel, which is environment-friendly as well as renewable, thereby reducing the pollution levels.

Request a sample pdf Copy of report @ https://goo.gl/YhiA4H

Key Trends and Analysis of Ethanol Market:

According to the State Council General Research Office, the U.S. government is promoting the use of ethanol as a source of renewable fuel and creating awareness regarding the social and environmental hazards caused by gasoline

Dry milling process is majorly adopted by the leading ethanol manufacturers in the U.S. Marquis Energy is the biggest dry mill ethanol facility with a production capacity of around 300 million gallons of fuel grade ethanol

Production of ethanol from secondary sources is gaining popularity. For instance, the Government of Australia is engaged in extensive research and development activities in order to convert sugarcane waste into liquid fuel, as a result, transforming the ethanol market in Australia

Significant demand for alcoholic beverages is another major factor driving the global ethanol market. According to Coherent Market Insights, the alcoholic beverages segment is expected to surpass US$ 18 billion by the end of 2017

Key Takeaways of the Market:

According to Coherent Market Insights, North America dominated the global ethanol market, valued at US$ 25,830.6 million in 2016. The region is projected to witness a CAGR of 0.45%, in terms of revenue, during the forecast period. According to the Renewable Fuels Association (RFA), the U.S. is the major export market for ethanol. The major import countries of ethanol from the U.S. are China, India, South Korea, Canada, and Brazil, among others.

Latin America is the second largest market for ethanol, accounting for over 35% share, in terms of revenue, wherein, Brazil holds a major share in the region

Asia Pacific is expected to experience significant growth potential over the forecast period. Tax rebates and favorable government regulations in China have boosted production as well as export of ethanol. Further, the government of China has set production targets for ethanol at 3.35 billion gallons by the end of 2020. Further, the commercial utilization of ethanol will allow for a reduction in energy import bill. In India, the blending target for ethanol is estimated at 20% in 2017. The Government of India has classified bamboo, rice, wheat straw, and cotton straw as second generation ethanol sources to boost the production of ethanol in India.

Get discount on this report : https://goo.gl/ZJhpzq

Archer Daniels Midland Company, Cargill, Inc., Grain Processing Corporation, Ace Ethanol LLC, Advanced BioEnergy, LLC, MGP Ingredients, Flint Hills Resources LP, and Marquis Energy are some of the leading players in the global ethanol market. In 2013, Cargill Inc. expanded its operation in Germany by setting up a new ethanol plant in Barby. The new plant is aimed at producing ethanol for Europe’s alcoholic beverage, pharmaceutical, and cosmetic industries.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/

Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

Asparagus Market - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2017-2025

4:23 pm 27 September 2017

Asparagus is a spring vegetable, herbaceous and high value flowering perennial plant with stout stems with much branched, feathery foliage. It is a member of lily family which also includes leeks, garlic, and onion. One of the key factors for the growth of asparagus market is that it aids in bone health and blood clotting as asparagus contains vitamin K, vitamin C, folates and little bit of tryptophan. Increasing consumer demand for organic products made of asparagus has made organic crop production one of the fastest growing segments of asparagus market. Asparagus helps consumer to boost their immunity, enhance brain function and at some extent, fight cancer is projected to the growth of asparagus market. Increasing awareness regarding health benefits of consuming asparagus among population is expected to the growth of asparagus market.

Request a sample pdf Copy of report @ https://goo.gl/BfbbFm

Asparagus Market Taxonomy-

On the basis of color, the global market is classified into:

White

Green

Purple

On the basis of product type, the global market is classified into:

Canned

Fresh

Frozen

On the basis of source, the global market is classified into:

Vitamin B

Calcium

Magnesium

Zinc

Dietary Fiber

Protein

Beta-Carotene

Thiamin

Riboflavin

Rutin

Potassium

Copper

Others

On the basis of application, the global market is classified into:

Pharmaceutical

Cancer

Heart Disease

Blood Sugar

Others

Health Care

Food ingredients

Cosmetics

Others

On the basis of distribution channel, the global market is classified into:

Local Retailers

Road Side Stands

Large Supermarkets

Online

Others

The rise in demand for the anti-aging creams drives growth of the cosmetic application segment. In addition to rich source in vitamins, asparagus also consists of anti-oxidant properties is projected to the growth of asparagus market. Asparagus along with vegetable also considered as medicinal plant as it helps in maintaining cholesterol level in the body and reduce blood pressure level are some of the drivers which attract the pharmaceutical companies and fuel to the growth of asparagus market. Along with this, asparagus offers wide variety of taste and texture is expected to the growth of asparagus market.

Get discount on this report : https://goo.gl/ccS7Th

Asparagus Market Outlook-

Europe is the largest manufacturer of asparagus followed by North America and Western Asia. Presently, asparagus is used in starter and salad in restaurants led to growth of the asparagus market. Cost of packaging, cooling transportation is relatively high which increases the price of asparagus. The U.S. consumption of fresh asparagus increased rapidly as compared to canned asparagus and frozen asparagus enabling opportunities for exporting countries to be able to provide out of season produce. According to Agricultural Marketing Resource Center, asparagus is a low calorie, nutritious vegetable that is high in vitamin C and iron and one cup of asparagus contains 3 grams of protein which leads to the high production of asparagus market, hence is expected to fuel the growth of asparagus market during the forecast period. According to Non-Traditional Agricultural Exports, asparagus is the chief product in Peru. Peruvian exports enhanced due to competitiveness which originated from favorable climate, soil, labor and production factors.

Pickled asparagus sauces and soups and brine lead to an increasing demand for fresh asparagus products, asparagus is used as key ingredients in soups due to its palatable taste and its nutritive value and has broadly become the choice of soup manufacturing industry, which is expected to propel the growth of global asparagus market in terms of value and volume.

Various asparagus manufacturing companies mainly focusing on product development and are implementing new innovations and technology to achieve better market position in the global asparagus market. In May 2017, Limgroup introduced Aspalim and Portlim, to enhance their product portfolio and to expand their position in the global asparagus market.

Some of the key players in the global asparagus market are Altar Produce, DanPer, Limgroup, TEBOZA Asparagus, Viru(Natural Ahead), , Cutter Asparagus Seed, Mazzoni S.p.A., Walker Plants, Spargelhof Elsholz, ILIOS –The Greek Asparagus Company, California Asparagus Seed and Transplants, Inc., Gourmet Trading Company and Motta Produce.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/

Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights